AI assistant
IMMUTEP LIMITED — Director's Dealing 2012
Apr 30, 2012
65122_rns_2012-04-30_8b07e0ce-6fd3-4dc6-ae60-23d8c39cb2f0.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of Entity: PRIMA BIOMED LTD (ASX:PRR) ACN: 90 009 237 889
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director: Dr Neil Frazer
Date of Last Notice: 08.08 .2011
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct | Direct | Direct | |
|---|---|---|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
- | |||
| Date of change | 27 April 2012 | |||
| No. of securities held prior to change | 1) Ordinary Fully Paid Shares Shares Options Direct - 2,000,000 Indirect - - Total - 2,000,000 |
|||
| Shares | Options | |||
| Direct | - | 2,000,000 | ||
| Indirect | - | - | ||
| **Total ** | - | 2,000,000 | ||
| Class | 2) American Depositary Receipts (ADR) traded on the NASDAQ 1 ADR = 30 ordinary fully paid shares |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | 2.) American Depositary Receipts (ADR) Shares Options Direct 1,000 - Indirect - - Total 1,000 - |
2.) American Depositary Receipts (ADR) Shares Options Direct 1,000 - Indirect - - Total 1,000 - |
2.) American Depositary Receipts (ADR) Shares Options Direct 1,000 - Indirect - - Total 1,000 - |
2.) American Depositary Receipts (ADR) Shares Options Direct 1,000 - Indirect - - Total 1,000 - |
|
|---|---|---|---|---|---|
| Shares | Options | ||||
| Direct | 1,000 | - | |||
| Indirect | - | - | |||
| Total | 1,000 | - | |||
| Number disposed | Options - - - |
||||
| Shares | Options | ||||
| Direct | - | - | |||
| Indirect | - | - | |||
| Total | - | - | |||
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
US$ 7,000.00 | ||||
| No. of securities held after change | 1) Ordinary Fully Paid Shares 2) American DepositaryReceipts(ADR) Shares Options Direct 1,000 - Indirect - - Total 1,000 - Shares Options Shares Options Direct 112,000 2,000,000 Indirect - - Total 112,000 2,000,000 |
||||
| Shares | Options | ||||
| Direct | 1,000 | - | |||
| Indirect | - | - | |||
| Total | 1,000 | - | |||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Acquiring 1,000 ADR’s at US$7.00 each that are traded on the NASDAQ |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| disclosed in this part. | |
|---|---|
| Detail of contract | N/A |
| Nature of interest | |
| Name of registered holder (if issued securities) |
|
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
|
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
|
| Interest after change |
Part 3 - +Closed Period
Were the interests in the securities or contracts detailed above traded No during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?
27.04.2012
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002